Rosenblum Mark J 4
4 · Salarius Pharmaceuticals, Inc. · Filed Mar 25, 2020
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Common Stock
2020-03-23+30,000→ 30,000 totalExercise: $0.61Exp: 2030-03-22→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]25% of the options granted are fully vested on March 23, 2021, and quarterly vesting of the remaining options over 3 years